News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
321,859 Results
Type
Article (19173)
Company Profile (86)
Press Release (302600)
Section
Business (104631)
Career Advice (840)
Deals (18458)
Drug Delivery (81)
Drug Development (50389)
Employer Resources (79)
FDA (7529)
Job Trends (7685)
News (184432)
Policy (17234)
Tag
Academia (726)
Africa (405)
Allergies (17)
Alliances (27547)
Alzheimer's disease (505)
Antibody-drug conjugate (ADC) (38)
Approvals (7497)
Arizona (39)
Artificial intelligence (47)
Asia (24115)
Australia (3090)
Bankruptcy (170)
Best Places to Work (5287)
Biosimilars (48)
C2C Services and Suppliers (13097)
California (424)
Canada (366)
Cancer (114)
Cardiovascular disease (18)
Career advice (684)
CAR-T (16)
Cell therapy (30)
China (30)
Clinical research (40708)
Collaboration (41)
COVID-19 (1028)
Cystic fibrosis (39)
Data (16)
Diabetes (25)
Diagnostics (1641)
Diversity, equity & inclusion (21)
Drug pricing (57)
Earnings (37234)
Employer resources (69)
Europe (49550)
Events (46495)
Executive appointments (18)
FDA (7549)
Florida (38)
Funding (19)
Gene editing (15)
Gene therapy (38)
GLP-1 (388)
Government (1754)
Healthcare (5802)
Hotbed/Location (218910)
Illinois (68)
Indiana (54)
Infectious disease (1041)
Inflammatory bowel disease (54)
Interviews (113)
IPO (7212)
IRA (19)
Job creations (2422)
Job search strategy (641)
Kansas (50)
Layoffs (232)
Legal (4047)
Liver cancer (25)
Lung cancer (29)
Management (26)
Manufacturing (39)
Maryland (71)
Massachusetts (231)
Medical device (1921)
Medtech (1922)
Mergers & acquisitions (11098)
Metabolic disorders (150)
NASH (14)
Neuroscience (555)
New Jersey (40)
New York (40)
NextGen Class of 2024 (2330)
Non-profit (895)
North Carolina (81)
Obesity (98)
Opinion (159)
Patents (28)
Pennsylvania (17)
People (32440)
Phase I (12639)
Phase II (17259)
Phase III (13896)
Podcasts (44)
Policy (35)
Postmarket research (1607)
Preclinical (4453)
Rare diseases (53)
Real estate (3156)
Recruiting (29)
Regulatory (11818)
Research institute (814)
Resumes & cover letters (138)
South America (601)
Startups (1999)
Texas (38)
United States (1326)
Vaccines (148)
Washington State (66)
Weight loss (107)
Date
Today (22)
Last 7 days (243)
Last 30 days (963)
Last 365 days (19084)
2024 (10780)
2023 (19635)
2022 (25866)
2021 (26639)
2020 (24871)
2019 (20058)
2018 (15587)
2017 (17255)
2016 (16202)
2015 (18802)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
321,859 Results for "neuway pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
NEUWAY Pharma Appoints Healthcare Sector Veteran Dr Jacques Mallet to its Advisory Board
NEUWAY Pharma GmbH announced the appointment of Dr Jacques Mallet as an additional independent member of the Advisory Board.
September 9, 2022
·
2 min read
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
Business
NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive Officer and Dr Thomas Christoph as Chief Development Officer
NEUWAY Pharma GmbH announced two new appointments in its senior leadership team: Dr Oliver Ernst, formerly NEUWAY’s Chief Operating Officer, was promoted to Chief Executive Officer, and Dr Thomas Christoph was appointed as new Chief Development Officer.
September 20, 2022
·
2 min read
FDA
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
June 26, 2024
·
10 min read
Pharmacy benefit managers
PBM Execs Point Fingers at Pharma Industry in House Hearing on Rising Drug Prices
Executives from the three largest pharmacy benefit manager companies testified Tuesday before Congress that rising drug prices in the U.S. are due to pharma companies taking advantage of market exclusivities and excessive charges.
July 24, 2024
·
2 min read
·
Tristan Manalac
Outcome of Innate Pharma’s 2024 Annual General Meeting
Innate Pharma SA announced the voting results of its shareholders at the Annual General Meeting, which took place on May 23, 2024, in Marseille.
May 23, 2024
·
3 min read
Altus Formulation and Spektar Join Forces in New Specialty Company Spektus Pharma
Spektar Therapeutics FZCO and Altus Formulation Inc. announced the launch of Spektus Pharma Inc. a new Canadian specialty pharma company developing patent-protected value-added medicines for the growing CNS segment.
June 18, 2024
·
2 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
LSL Pharma Group Completes the Acquisition of Virage Santé
LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé, a company specializing in the manufacturing and marketing of natural health products, based in Lévis, Quebec.
June 18, 2024
·
3 min read
NervGen Pharma Grants Stock Options.
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that the company has granted 950,000
June 7, 2024
·
1 min read
1 of 32,186
Next
